ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Balaxi Pharmaceuticals Ltd

NSE: BALAXI · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹23.35
Market cap: ₹128.9 Cr
Revenue (annual): ₹270.2 Cr
Net profit (annual): ₹1.42 Cr
P/E (TTM): 53.2×Sector 43.8×
Promoter holding: 65.99%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Financial Results 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

12 Nov 2026 13:58 IST NSE

Financial Results

Balaxi Pharmaceuticals Q2 FY27 Results: Net Profit ₹1.2 Cr, Up 500.0% YoY

Balaxi Pharmaceuticals Ltd reported revenue from operations of ₹81.4 Cr (+44.8% YoY) and net profit of ₹1.2 Cr (+500.0% YoY) for Q2 FY27.

Key figure: Net profit ₹1.2 Cr · +500.0% YoY

Open full results → Read the filing ↗

Balaxi Pharmaceuticals Ltd by type